Risk of Tighter Regulations on Mail-Order Sales and Product Labelling, Etc.
First written in FY2024. 1 of 2 entries say "Mitigated", first in FY2025. Latest entry: FY2025.
The whole theme swung hardest in 2025: 6 of 29 companies on the "Worse" side.
4 other companies' latest entry also says "Mitigated".
- FY2025MitigatedAnnual report
「The Group provides education on the importance of compliance and conducts its activities in accordance with its compliance rules, which establish the basic principles and decision-making criteria for day-to-day conduct. In selecting products and services, it makes decisions based on the paramount criterion of not betraying the trust of the senior generation.」
For regulatory risks relating to mail-order sales, product labelling and related activities, specific measures were established, including compliance training, internal rules, product-selection criteria and information gathering by the legal department. - FY2024First statedAnnual report
「In selling products and conducting other activities, the Group is subject to a very large number of legal regulations, including the Act against Unjustifiable Premiums and Misleading Representations, the Act on Specified Commercial Transactions and the Pharmaceuticals and Medical Devices Act. However, if business activities are restricted by tighter legal regulations or new regulations in the future, the Group's operating results and other aspects of its business may be affected.」
The risks identified are the multiple regulations relating to mail-order sales and product sales, and restrictions on business activities resulting from tighter or new regulations.